We’re thrilled to launch the Catalyst program, our Early Access initiative that brings INDUCE-seq® directly into gene editing labs. Now, therapy developers can detect on- and off-target effects in days instead of months—accelerating development while ensuring safety.

By bringing INDUCE-seq® in-house, researchers gain faster insights, regulatory confidence, and real-time guide selection—a game-changer for gene editing safety. Enrollment is limited—apply here: brokenstringbio.com/resources/cata… #GeneEditing #Biotech #CRISPR